Two Sigma Securities, LLC Trevena Inc Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.16 - $100.0 $9,968 - $6.23 Million	62,300 New	62,300 $10,000
Q1 2022 May 16, 2022	SELL	$0.41 - $0.63 $15,166 - $23,304	-36,991 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.29 $21,084 - $47,718	36,991 New	36,991 $22,000
Q1 2021 May 17, 2021	SELL	$1.77 - $2.93 $41,956 - $69,452	-23,704 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $50,489 - $77,275	23,704 New	23,704 $51,000
Q3 2019 Nov 14, 2019	SELL	$0.81 - $1.06 $16,832 - $22,027	-20,781 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.94 - $1.6 $19,534 - $33,249	20,781 New	20,781 $21,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.